X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Vivimed Labs Ltd.
BSE CODE: 532660   |   NSE CODE: VIVIMEDLAB   |   ISIN CODE : INE526G01021   |   18-Dec-2025 Hrs IST
BSE NSE
Rs. 26.51
21.61 ( 441.02% )
 
Prev Close ( Rs.)
4.90
Open ( Rs.)
27.90
 
High ( Rs.)
27.99
Low ( Rs.)
26.51
 
Volume
85039
Week Avg.Volume
40185
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 26.60
21.65 ( 437.37% )
 
Prev Close ( Rs.)
4.95
Open ( Rs.)
28.00
 
High ( Rs.)
29.40
Low ( Rs.)
26.60
 
Volume
228385
Week Avg.Volume
179574
 
52 WK High-Low Range(Rs.)
26.6
29.4
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)-3.80  -5.35  -39.56  -8.17  -2.81  
   CEPS(Rs)-1.55  -3.13  -26.67  -6.07  -0.90  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)2.47  6.20  11.50  50.57  58.67  
   Tax Rate(%)0.00  0.00  0.64  -4.34  1.00  
Margin Ratios          
   Core EBITDA Margin(%)-14.01  -24.22  -106.27  -4.14  13.29  
   EBIT Margin(%)-27.95  -30.68  -166.59  -11.55  8.70  
   Pre Tax Margin(%)-30.40  -32.44  -186.70  -29.74  -11.19  
   PAT Margin (%)-30.40  -32.44  -185.50  -31.03  -11.08  
   Cash Profit Margin (%)-12.42  -18.99  -125.04  -23.04  -3.56  
Performance Ratios          
   ROA(%)-4.77  -6.01  -35.12  -6.25  -2.15  
   ROE(%)-87.61  -60.50  -127.49  -14.96  -4.64  
   ROCE(%)-7.04  -9.34  -47.20  -3.18  2.24  
   Asset Turnover(x)0.16  0.19  0.19  0.20  0.19  
   Sales/Fixed Asset(x)0.20  0.27  0.33  0.40  0.42  
   Working Capital/Sales(x)-0.71  -1.18  -1.25  2.87  1.63  
Efficiency Ratios          
   Fixed Capital/Sales(x)4.93  3.70  3.03  2.52  2.37  
   Receivable days185.55  146.54  117.34  117.08  144.55  
   Inventory Days210.09  188.21  327.56  411.82  449.25  
   Payable days226.76  258.17  63.72  89.46  119.79  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)0.00  0.00  -0.25  -2.38  -17.56  
   Price/Book(x)0.00  0.00  0.58  0.29  0.27  
   Yield(%)0  0  0.00  0.00  0.00  
   EV/Net Sales(x)3.78  2.86  2.42  2.15  2.14  
   EV/Core EBITDA(x)-37.87  -16.59  -2.28  -60.43  13.18  
   EV/EBIT(x)-13.51  -9.31  -1.45  -18.63  24.57  
   EV/CE(x)0.99  0.92  0.91  0.61  0.55  
   M Cap / Sales0.00  0.00  0.31  0.55  0.63  
Growth Ratio          
   Net Sales Growth(%)-24.26  -22.64  -19.02  3.96  -24.06  
   Core EBITDA Growth(%)56.16  87.45  -2313.12  -122.83  -13.27  
   EBIT Growth(%)31.00  85.75  -1067.76  -238.12  -19.54  
   PAT Growth(%)29.03  86.47  -384.13  -191.04  -21.43  
   EPS Growth(%)29.03  86.47  -384.13  -191.04  -21.43  
Financial Stability Ratios          
   Total Debt/Equity(x)18.29  7.30  3.95  0.85  0.66  
   Current Ratio(x)0.63  0.71  0.66  1.21  1.39  
   Quick Ratio(x)0.49  0.54  0.47  0.55  0.62  
   Interest Cover(x)-11.41  -17.39  -8.29  -0.64  0.44  
   Total Debt/Mcap(x)0  0  6.81  2.98  2.46